Geographic Disparities in Availability of Opioid Use Disorder Treatment for Medicaid Enrollees

被引:60
|
作者
Abraham, Amanda J. [1 ]
Andrews, Christina M. [2 ]
Yingling, Marissa E. [3 ]
Shannon, Jerry [4 ]
机构
[1] Univ Georgia, Sch Publ & Int Affairs, Dept Publ Adm & Policy, 202A Baldwin Hall 355 S Jackson St, Athens, GA 30602 USA
[2] Univ South Carolina, Hamilton Coll, Coll Social Work, Columbia, SC USA
[3] Clemson Univ, Coll Behav Social & Hlth Sci, Dept Sociol & Anthropol, Clemson, SC USA
[4] Univ Georgia, Dept Geog, Athens, GA 30602 USA
关键词
Medicaid; opioid use disorder; access; opioid treatment programs; ABUSE TREATMENT GAPS; PHYSICIAN PARTICIPATION; TREATMENT PROGRAMS; UNITED-STATES; COVERAGE; ACCESS; REFORM;
D O I
10.1111/1475-6773.12686
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
ObjectiveTo examine county-level geographic variation in treatment admissions among opioid treatment programs (OTPs) that accept Medicaid in the continental United States. Data Sources/Study SettingData come from the 2012 National Survey of Substance Abuse Treatment Services. Study Design/Data CollectionWe used local measures of spatial autocorrelation (LISA) analysis to identify (1) clusters of counties with higher and lower than average rates of opioid use disorders and (2) clusters of counties with higher and lower than average treatment admissions among OTPs that accept Medicaid, adjusting for county population size. Principal FindingsOur results reveal several clusters of counties with higher than average rates of opioid use disorder (OUD) and lower than average treatment admissions among OTPs that accept Medicaid. These clusters are highly concentrated in the Southeast region of the country and include Arkansas, Kentucky, Louisiana, Mississippi, and Tennessee. ConclusionsMedicaid enrollees in areas in the Southeast have the largest gaps between county-level OUD rates and estimated county-level capacity for treatment, as measured by county-level total treatment admissions among OTPs that accept Medicaid. Policy makers should consider strategies to increase the availability of OTPs with the capacity to serve Medicaid enrollees.
引用
收藏
页码:389 / 404
页数:16
相关论文
共 50 条
  • [31] Treatment access for opioid use disorder among women with medicaid in Florida
    Elmore, Amanda L.
    Patrick, Stephen W.
    McNeer, Elizabeth
    Fryer, Kimberly
    Reid, Chinyere N.
    Sappenfield, William M.
    Mehra, Saloni
    Salemi, Jason L.
    Marshall, Jennifer
    DRUG AND ALCOHOL DEPENDENCE, 2023, 246
  • [32] Availability of Medications for the Treatment of Alcohol and Opioid Use Disorder in the USA
    Abraham, Amanda J.
    Andrews, Christina M.
    Harris, Samantha J.
    Friedmann, Peter D.
    NEUROTHERAPEUTICS, 2020, 17 (01) : 55 - 69
  • [33] Availability of Medications for the Treatment of Alcohol and Opioid Use Disorder in the USA
    Amanda J. Abraham
    Christina M. Andrews
    Samantha J. Harris
    Peter D. Friedmann
    Neurotherapeutics, 2020, 17 : 55 - 69
  • [34] Availability and Opportunities for Expansion of Buprenorphine for the Treatment of Opioid Use Disorder
    McKendrick, Greer
    Stull, Samuel W.
    Sharma, Anjalee
    Dunn, Kelly E.
    SEMINARS IN NEUROLOGY, 2024, 44 (04) : 419 - 429
  • [35] Pharmacy Availability of Buprenorphine for Opioid Use Disorder Treatment in the US
    Weiner, Scott G.
    Qato, Dima M.
    Faust, Jeremy Samuel
    Clear, Brian
    JAMA NETWORK OPEN, 2023, 6 (05) : E2316089
  • [36] Impact of Medicaid Expansion on Medicaid-covered Utilization of Buprenorphine for Opioid Use Disorder Treatment
    Wen, Hefei
    Hockenberry, Jason M.
    Borders, Tyrone F.
    Druss, Benjamin G.
    MEDICAL CARE, 2017, 55 (04) : 336 - 341
  • [37] Uncovering Barriers to Engagement in Substance Use Disorder Care for Medicaid Enrollees
    Falgas-Bague, Irene
    Zhen-Duan, Jenny
    Ferreira, Caroline
    Tahanasab, Sara A.
    Cuervo-Torello, Fernando
    Fukuda, Marie
    Markle, Sheri L.
    Alegria, Margarita
    PSYCHIATRIC SERVICES, 2023, 74 (11) : 1116 - 1122
  • [38] Medications For Opioid Use Disorder Increased Among Louisiana Medicaid Enrollees During Policy Reforms, 2018-21
    Sugarman, Olivia K.
    Li, Wenshu
    Saloner, Brendan
    HEALTH AFFAIRS, 2024, 43 (01) : 46 - 54
  • [39] Geographic disparities in access to Medication for Opioid Use Disorder across US census tracts based on treatment utilization behavior
    Mitchell, Penelope
    Samsel, Steven
    Curtin, Kevin M.
    Price, Ashleigh
    Turner, Daniel
    Tramp, Ryan
    Hudnall, Matthew
    Parton, Jason
    Lewis, Dwight
    SOCIAL SCIENCE & MEDICINE, 2022, 302
  • [40] Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees
    Samples, Hillary
    Williams, Arthur Robin
    Olfson, Mark
    Crystal, Stephen
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2018, 95 : 9 - 17